US20120107320 - Antibodies specifically directed to the soluble form of CTLA-4

Frank James Ward (Inventor), Robert Norman Barker (Inventor), Lekh Nath Dahal (Inventor)

Research output: Patent

Abstract

The invention provides materials and methods relating to antibodies specific for the soluble form of CTLA-4 (sCT-LA-4). Such antibodies have been shown to have a strong boosting effect on antigen-specific human immune responses.
Original languageEnglish
IPCUS20120107320
Publication statusPublished - 28 Feb 2009

Keywords

  • antibody
  • costimulation
  • CTLA4

Fingerprint Dive into the research topics of 'US20120107320 - Antibodies specifically directed to the soluble form of CTLA-4'. Together they form a unique fingerprint.

  • Cite this

    Ward, F. J., Barker, R. N., & Dahal, L. N. (2009). IPC No. US20120107320. US20120107320 - Antibodies specifically directed to the soluble form of CTLA-4.